Cargando…
Myocardial Restoration: Is It the Cell or the Architecture or Both?
Myocardial infarction is the leading cause of death in developed countries. Cardiac cell therapy has been introduced to clinical trials for more than ten years but its results are still controversial. Tissue engineering has addressed some limitations of cell therapy and appears to be a promising sol...
Autores principales: | Vu, Duc Thang, Kofidis, Theo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286902/ https://www.ncbi.nlm.nih.gov/pubmed/22400122 http://dx.doi.org/10.1155/2012/240497 |
Ejemplares similares
-
Erratum to “Myocardial Restoration: Is It the Cell or the Architecture or Both?”
por: Vu, Duc Thang, et al.
Publicado: (2012) -
Targeted Myocardial Restoration with Injectable Hydrogels—In Search of The Holy Grail in Regenerating Damaged Heart Tissue
por: Sazzad, Faizus, et al.
Publicado: (2021) -
Mitral valve repair update: simple, intuitive and physiological techniques, using running sutures (part II)
por: Kofidis, Theo
Publicado: (2023) -
A mitral valve repair update: simple, intuitive and physiological techniques, using running sutures (part I)
por: Kofidis, Theo
Publicado: (2023) -
Mitral valve re-repair vs replacement following failed initial repair: a systematic review and meta-analysis
por: Veerappan, Muthu, et al.
Publicado: (2020)